Benefit-risk balance for marketed drugs: evaluating safety signals

Benefit-risk balance for marketed drugs: evaluating safety signals

Spremljeno u:

Bibliografski detalji
Autor kompanije:	Council for International Organizations of Medical Sciences (CIOMS)
Format:	Knjiga
Jezik:	English
Izdano:	Geneva Council for International Organizations of Medical Sciences (CIOMS) 1998
Teme:	Drugs Pharmaceutic Preparations Pharmaceutical Products Preparations, Pharmaceutical
Online pristup:	Visit NHRC Library
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items

Martindale: the complete drug reference
od: Parfitt, Kathleen
Izdano: (1999)

WHO drug information.
Izdano: (2000)

WHO expert committee on specifications for pharmaceutical preparations
Izdano: (2006)

International nonproprietary names (INN) for pharmaceutical substances : lists 1-65 of proposed INN and lists 1-31 of recommended INN : cumulative list no. 8 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées : liste récapitulative no. 8.
Izdano: (1992)

WHO expert committee on specifications for pharmaceutical preparations
Izdano: (2011)

WHO Expert Committee on Specifications for Pharmaceutical Preparations
Izdano: (2012)

USP DI. Approved drug products and legal requirements.
Izdano: (1995)

Where there are no pharmacists : a guide to managing medicines for all health workers /
od: Andersson, Sarah
Izdano: (2010)

Managing drug supply : the selection, procurement, distribution, and use of pharmaceuticals. the selection, procurement, distribution, and use of pharmaceuticals.
Izdano: (1997)

Pharmacology : a patient-centered nursing process approach /
od: Kee, Joyce LeFever, i dr.

Drug calculations : ratio and proportion problems for clinical practice /
od: Seltzer, Meta Brown, i dr.

Effective drug regulation a multicountry study /
od: Ratanawijitrasin, Sauwakon
Izdano: (2002)

WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /

Preparation of hazardous waste inventory
od: DEVS Consult Nepal (P) Ltd.
Izdano: (2013)

Client satisfaction and quality of curative services for sick children in Nepal: further analysis of the 2015 Nepal Health Facility Survey: DHS further analysis reports No. 114.
od: Acharya,Kiran
Izdano: (2018)

Regulatory Situation of Herbal Medicines
Izdano: (1998)

A text book of pharmacognosy.
od: Raut, Bechan, i dr.
Izdano: (2007)

Status of Ayurvedic Medicines Available in the Markets of Nepal
od: Adhikari, SM, i dr.
Izdano: (2016)

The Selection and Use of Essential Medicines Reports of the WHO Expert Committee on the Selection and Use of Essential Medicines and the 3rd WHO Model list of essential medicines for children
Izdano: (2012)

AHFS drug information 2000
od: Snow, Elaine, K
Izdano: (2000)

Safety requirements for the first use of new drugs and diagnostic agents in man : a review of safety issues in early clinical trials of drugs.
Izdano: (1983)

Final Report on Development of Profile of Toxic Waste Products in Nepal
od: Nepal Health Research Council (NHRC), i dr.
Izdano: (2013)

Serotyping and antibiotic resistance profile of common bacterial isolates causing gastroenteritis.
od: Yadav, Raju
Izdano: (2016)

Ensuring balance in national policies on control substances: Guidelines for availability and accessibility of controlled medicines
Izdano: (2011)

Clinical trials: study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines
od: Brody, Tom
Izdano: (2016)

Evaluation of certain veterinary drug residues in food
Izdano: (2000)

WHO Expert Committee on biological standardization sixty-fourth meeting report /

Study on the Projection and Management of Health Care Professionals for the Next Ten Years
od: Aryal, BK, i dr.
Izdano: (2016)

Impact of educational intervention on knowledge and practice of safety precaution of cytotoxic drugs administration among nurse.
od: Pande, Sarala
Izdano: (2011)

Status of Ayurvedic medicines available in the markets of Nepal
od: Adhikari, Shyam Mani
Izdano: (2008)

Status of Ayurvedic Medicines Available in the Markets of Nepal
od: Adhikari, Shyam Mani, Dr.
Izdano: (2012)

Evaluation of certain veterinary drug residues in food: Forty- second report of the joint FAO/WHO expert committee on food additives
Izdano: (1995)

Fundamentals of Clinical Trials /
od: Friedman, Lawrence M, i dr.
Izdano: (2015)

Evaluation of certain veterinary drug residues in food : seventy-fifth[75th] report of the Joint FAO/WHO Expert Committee on Food Additives
Izdano: (2012)

The use of essential drugs : ninth report of the WHO Expert Committee (including the revised Model list of essential drugs).
Izdano: (2000)

Drug policy in the Americas
od: Smith, Peter H.
Izdano: (1992)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Izdano: (2011)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Izdano: (2011)

Iodized salt social marketing campaign (ISMAC): Baseline Study
od: Poudel, Krishna Prasad
Izdano: (2015)

Public Health Care Expenditures in Nepal: Review, Analysis and Assessment
od: Maskay, NM, i dr.
Izdano: (2016)